Profile
Torbjörn Wärnheim worked as an Executive VP and Manager of Research & Development at Moberg Pharma AB from 2019 to 2021.
He also worked as a Vice President of Research & Development at Fresenius Kabi AB.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
OLINK HOLDING AB
0.00% | 04/02/2024 | 558 ( 0.00% ) | 12 873 $ | 29/04/2024 |
Former positions of Torbjörn Wärnheim
| Companies | Position | End |
|---|---|---|
| MOBERG PHARMA AB | Chief Tech/Sci/R&D Officer | 31/08/2021 |
Fresenius Kabi AB
 Fresenius Kabi AB Medical SpecialtiesHealth Technology Fresenius Kabi AB specializes in clinical nutrition, infusion therapy, and medical technology. It offers products for the collection and treatment of blood components and for the treatment of patient blood through therapeutic apheresis. The firm also develops products with a focus on oncology and autoimmune diseases. The company is headquartered in Uppsala, Sweden. | Chief Tech/Sci/R&D Officer | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| MOBERG PHARMA AB | Health Technology |
| Private companies | 1 |
|---|---|
Fresenius Kabi AB
Fresenius Kabi AB Medical SpecialtiesHealth Technology Fresenius Kabi AB specializes in clinical nutrition, infusion therapy, and medical technology. It offers products for the collection and treatment of blood components and for the treatment of patient blood through therapeutic apheresis. The firm also develops products with a focus on oncology and autoimmune diseases. The company is headquartered in Uppsala, Sweden. | Health Technology |
- Stock Market
- Insiders
- Torbjörn Wärnheim
